Drugs Made In America Acquisition II Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DMIIR | APUS | ANIP | ACXP | AMRX | JNJ | |
|---|---|---|---|---|---|---|
| Market cap | — | 4.77M | 1.69B | 6.34M | 7.13B | 644.91B |
| P/E (TTM) | — | — | 16.0 | — | 41.8 | 40.6 |
| Forward P/E | — | — | 7.3 | -0.7 | 17.0 | 23.0 |
| Price/book | -0.2 | 4.9 | 2.6 | 0.7 | 198.8 | 7.6 |
| Dividend yield | — | — | — | — | — | 2.08% |
| 1-year change | — | −81.26% | −23.88% | −82.31% | +93.86% | +33.93% |
| Today | +33.08% | −2.77% | +2.09% | −0.87% | +1.39% | +3.81% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All DMIIR news ›Drugs Made In America Acquisition II Corp. News — NASDAQ:DMII
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.